| Khalid Hassan Ashai, MD | |
|
7525 Greenway Center Dr, Suite 313, Greenbelt, MD 20770-3509 | |
| (301) 345-4100 | |
| (301) 345-1375 |
| Full Name | Khalid Hassan Ashai |
|---|---|
| Gender | Male |
| Speciality | Cardiovascular Disease (cardiology) |
| Experience | 36 Years |
| Location | 7525 Greenway Center Dr, Greenbelt, Maryland |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1912986035 | NPI | - | NPPES |
| 402330700 | Medicaid | MD |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207RC0000X | Internal Medicine - Cardiovascular Disease | D0060339 (Maryland) | Primary |
| 207RI0011X | Internal Medicine - Interventional Cardiology | D0060339 (Maryland) | Secondary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Adventist Healthcare White Oak Medical Center | Silver spring, MD | Hospital |
| Doctors' Community Hospital | Lanham, MD | Hospital |
| Entity Name | Adventist Physician Services Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1376623207 PECOS PAC ID: 4284631540 Enrollment ID: O20061030000122 |
News Archive
Two multinational clinical studies indicate that the RDI's system for predicting how HIV and AIDS patients will respond to different drugs could be a useful tool with potential clinical and economic benefits. The studies, published in the January issue of AIDS Patient Care and STDs, involved highly experienced physicians in the USA, Canada and Italy who used the system to help them select the optimum combination of HIV drugs for patients whose therapy was failing.
In a first, a city hospital has launched a clinic dedicated to vertigo. Dr Rajeev Boudhankar, vice-president, Kohinoor Hospital, said, "We observed that vertigo is a highly under-diagnosed ailment and patients run from post to pillar looking for effective treatment.
Yale researchers describe a breakthrough in safe and effective administration of potential antiviral drugs - small interfering RNA (siRNA) molecules that silence genes - the first step in development of a new kind of treatment for sexually transmitted diseases (STDs). The work is reported May 4 as an advance online publication of Nature Materials.
The elusive goal of developing effective treatments for viral diseases such as AIDS and influenza has been brought closer by dramatic progress in the ability to interfere with viral genetic machinery. The stage was set for a coordinated European effort to accelerate research and stimulate development of new treatments against viral diseases at a recent research conference organised by the European Science Foundation (ESF).
Having poor socioeconomic conditions - such as a lower occupational position - can take away 2.1 years of life on average from a person.
› Verified 2 days ago
| Entity Name | Ace Cardiovascular Associates Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1043454556 PECOS PAC ID: 6002969698 Enrollment ID: O20090729000576 |
News Archive
Two multinational clinical studies indicate that the RDI's system for predicting how HIV and AIDS patients will respond to different drugs could be a useful tool with potential clinical and economic benefits. The studies, published in the January issue of AIDS Patient Care and STDs, involved highly experienced physicians in the USA, Canada and Italy who used the system to help them select the optimum combination of HIV drugs for patients whose therapy was failing.
In a first, a city hospital has launched a clinic dedicated to vertigo. Dr Rajeev Boudhankar, vice-president, Kohinoor Hospital, said, "We observed that vertigo is a highly under-diagnosed ailment and patients run from post to pillar looking for effective treatment.
Yale researchers describe a breakthrough in safe and effective administration of potential antiviral drugs - small interfering RNA (siRNA) molecules that silence genes - the first step in development of a new kind of treatment for sexually transmitted diseases (STDs). The work is reported May 4 as an advance online publication of Nature Materials.
The elusive goal of developing effective treatments for viral diseases such as AIDS and influenza has been brought closer by dramatic progress in the ability to interfere with viral genetic machinery. The stage was set for a coordinated European effort to accelerate research and stimulate development of new treatments against viral diseases at a recent research conference organised by the European Science Foundation (ESF).
Having poor socioeconomic conditions - such as a lower occupational position - can take away 2.1 years of life on average from a person.
› Verified 2 days ago
| Entity Name | Choudry, Ijaz And Ali P.a.. |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1073889069 PECOS PAC ID: 7911169420 Enrollment ID: O20120511000275 |
News Archive
Two multinational clinical studies indicate that the RDI's system for predicting how HIV and AIDS patients will respond to different drugs could be a useful tool with potential clinical and economic benefits. The studies, published in the January issue of AIDS Patient Care and STDs, involved highly experienced physicians in the USA, Canada and Italy who used the system to help them select the optimum combination of HIV drugs for patients whose therapy was failing.
In a first, a city hospital has launched a clinic dedicated to vertigo. Dr Rajeev Boudhankar, vice-president, Kohinoor Hospital, said, "We observed that vertigo is a highly under-diagnosed ailment and patients run from post to pillar looking for effective treatment.
Yale researchers describe a breakthrough in safe and effective administration of potential antiviral drugs - small interfering RNA (siRNA) molecules that silence genes - the first step in development of a new kind of treatment for sexually transmitted diseases (STDs). The work is reported May 4 as an advance online publication of Nature Materials.
The elusive goal of developing effective treatments for viral diseases such as AIDS and influenza has been brought closer by dramatic progress in the ability to interfere with viral genetic machinery. The stage was set for a coordinated European effort to accelerate research and stimulate development of new treatments against viral diseases at a recent research conference organised by the European Science Foundation (ESF).
Having poor socioeconomic conditions - such as a lower occupational position - can take away 2.1 years of life on average from a person.
› Verified 2 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Khalid Hassan Ashai, MD 7525 Greenway Center Dr, Suite 313, Greenbelt, MD 20770-3509 Ph: (301) 345-4100 | Khalid Hassan Ashai, MD 7525 Greenway Center Dr, Suite 313, Greenbelt, MD 20770-3509 Ph: (301) 345-4100 |
News Archive
Two multinational clinical studies indicate that the RDI's system for predicting how HIV and AIDS patients will respond to different drugs could be a useful tool with potential clinical and economic benefits. The studies, published in the January issue of AIDS Patient Care and STDs, involved highly experienced physicians in the USA, Canada and Italy who used the system to help them select the optimum combination of HIV drugs for patients whose therapy was failing.
In a first, a city hospital has launched a clinic dedicated to vertigo. Dr Rajeev Boudhankar, vice-president, Kohinoor Hospital, said, "We observed that vertigo is a highly under-diagnosed ailment and patients run from post to pillar looking for effective treatment.
Yale researchers describe a breakthrough in safe and effective administration of potential antiviral drugs - small interfering RNA (siRNA) molecules that silence genes - the first step in development of a new kind of treatment for sexually transmitted diseases (STDs). The work is reported May 4 as an advance online publication of Nature Materials.
The elusive goal of developing effective treatments for viral diseases such as AIDS and influenza has been brought closer by dramatic progress in the ability to interfere with viral genetic machinery. The stage was set for a coordinated European effort to accelerate research and stimulate development of new treatments against viral diseases at a recent research conference organised by the European Science Foundation (ESF).
Having poor socioeconomic conditions - such as a lower occupational position - can take away 2.1 years of life on average from a person.
› Verified 2 days ago
Michael A Schwartz, M.D. Cardiovascular Disease Medicare: Not Enrolled in Medicare Practice Location: 7500 Hanover Pkwy, Suite 204, Greenbelt, MD 20770 Phone: 301-345-7878 | |
Gaurav Lakhanpal, MD Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 7300 Hanover Dr, Suite 104, Greenbelt, MD 20770 Phone: 301-486-4690 Fax: 301-486-4692 | |
Dr. Irfan Ahsan Khan, MD Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 7501 Greenway Center Dr, Suite 730, Greenbelt, MD 20770 Phone: 301-474-0400 Fax: 301-474-2686 | |
Mr. Ibrahim Jalloh, FNP Cardiovascular Disease Medicare: Medicare Enrolled Practice Location: 7500 Hanover Pkwy, Greenbelt, MD 20770 Phone: 301-441-8696 | |
Acquanetta Frazier, M.D. Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 8723 Greenbelt Rd Ste 201, Greenbelt, MD 20770 Phone: 301-552-9797 | |
Mushtaq Shah, M.D. Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 7227 Hanover Pkwy Ste A, Greenbelt, MD 20770 Phone: 301-220-0606 Fax: 301-513-9049 | |
Dr. Pimolvarn Limpuangthip, MD Cardiovascular Disease Medicare: Medicare Enrolled Practice Location: 7721 Belle Point Dr, Greenbelt, MD 20770 Phone: 301-345-1272 Fax: 301-474-2671 |